Here, Dr Natasha Varvogli, intellectual property consultant, and Maria Andrielou, marketing & communication at VIO Chemicals, look at patents and their role in the pharma industry, asking the question whether they are complicating business or enhancing opportunities?
VIO Chemicals
With pharma’s portfolio shifting substantially toward new product types and personalised treatments, process technology needs to overcome multiple challenges across the supply chain. Competition is fierce and the need for new and revolutionary solutions for drug development starts as early as the selection of the optimal route of synthesis and starting material, often calling for ‘out-of-the-box’ thinking.